| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥34.0B | - | +24.2% |
| Operating Income | ¥-2.4B | - | - |
| Ordinary Income | ¥-2.4B | - | - |
| Net Income | ¥-2.2B | - | - |
| ROE | -11.6% | - | - |
JSH Corporation's FY2026 Q3 cumulative results show revenue of 34.0B yen (YoY +24.2%), while recording an operating loss of 2.4B yen, ordinary loss of 2.4B yen, and net loss of 2.2B yen. Despite achieving solid top-line growth, the company remains in negative territory across all profit metrics. Gross profit margin stands at 27.5% with gross profit of 9.3B yen, indicating stable value creation at the product level, but selling, general and administrative expenses of 11.8B yen significantly exceed gross profit, driving the operating loss. Total assets increased to 38.4B yen from 29.8B yen in the prior period, while total equity decreased to 18.7B yen from 20.4B yen, reflecting loss accumulation. The company forecasts full-year revenue of 49.3B yen with an operating loss of 1.3B yen, suggesting anticipated improvement in the fourth quarter.
Revenue increased 24.2% YoY to 34.0B yen, demonstrating continued business expansion. This growth was primarily driven by the Regional Revitalization Business segment, which generated revenue of 2.28B yen with segment profit of 434.5M yen, and the Home Medical Care Business segment, which contributed revenue of 1.06B yen but recorded a segment loss of 142.2M yen. The Other segment (IoT Solution Services) added 56.7M yen in revenue with a loss of 60.7M yen. Cost of sales increased proportionally to 24.6B yen, maintaining a stable gross margin of 27.5%. However, SG&A expenses of 11.8B yen, representing 34.6% of revenue, exceeded gross profit and included approximately 472.0M yen in unallocated corporate expenses not assigned to reporting segments. This structural cost burden is the primary driver of operating losses. No extraordinary items such as impairment losses or asset sales were reported during the period. Non-operating income and expenses were minimal at approximately negative 20M yen net, showing limited impact on the gap between operating and ordinary income. The pattern represents revenue growth with profit decline, where top-line expansion has not translated into profitability due to elevated fixed cost structure and insufficient operating leverage.
The Regional Revitalization Business is the core segment, generating 2.28B yen in revenue (67.1% of total segment revenue) and achieving segment profit of 434.5M yen with a segment margin of 19.1%. This segment demonstrates profitability and represents the company's primary earnings driver. The Home Medical Care Business contributed 1.06B yen in revenue (31.2% of segment total) but recorded a segment loss of 142.2M yen, indicating a negative segment margin of 13.4%. This loss-making position suggests the business is either in investment phase or facing operational challenges. The Other segment (IoT Solution Services) generated 56.7M yen in revenue with a segment loss of 60.7M yen, representing a small but unprofitable operation. Unallocated corporate expenses of 472.0M yen significantly eroded the combined segment profit of 292.3M yen, resulting in the consolidated operating loss of 240.5M yen. The material margin difference between segments highlights the Regional Revitalization Business as the profitable anchor while Home Medical Care requires operational improvement.
[Profitability] ROE of negative 11.6% reflects loss-making operations, deteriorating from prior periods. Operating margin of negative 7.1% and net profit margin of negative 5.8% indicate structural profitability challenges, with SG&A expenses consuming 34.6% of revenue compared to gross margin of 27.5%. DuPont analysis shows ROE decomposition of negative 5.8% net profit margin multiplied by 0.885 asset turnover and 2.05 financial leverage. [Cash Quality] Cash and deposits stand at 9.4B yen, providing substantial liquidity coverage. Short-term debt coverage measured by cash to current liabilities ratio reaches 1.11x. Working capital of 8.0B yen supports operations, though receivables turnover shows collection period of approximately 61 days. [Investment Efficiency] Asset turnover of 0.885 indicates moderate asset utilization, with total assets of 38.4B yen generating revenue at below one-time annual rate. Return on assets of negative 5.7% reflects unprofitable asset deployment. [Financial Health] Equity ratio of 48.7% provides reasonable capital cushion. Current ratio of 194.5% demonstrates strong short-term liquidity position. Debt-to-equity ratio of 0.50 remains manageable, though long-term loans increased substantially to 8.4B yen from 0.9B yen in the prior period, representing 820% growth and indicating significant new debt financing.
Cash and deposits increased to 9.4B yen, maintaining adequate liquidity for operations. The company holds current assets of 16.5B yen against current liabilities of 8.5B yen, yielding a working capital buffer of 8.0B yen. The substantial increase in long-term loans from 0.9B yen to 8.4B yen suggests significant debt financing activity during the period, likely to fund business expansion or asset acquisitions reflected in the 5.5B yen increase in property, plant and equipment. Inventories remain minimal at 0.1B yen, reflecting a light inventory business model. Accounts receivable management shows collection period of approximately 61 days, warranting attention to working capital efficiency. Retained earnings decreased by 2.0B yen, reflecting accumulated losses that consumed internal cash generation. The cash coverage of short-term liabilities stands at 1.11x, providing reasonable buffer for near-term obligations. Long-term debt financing appears to support the 44% increase in fixed assets, suggesting capital investment in growth infrastructure.
Ordinary income of negative 2.4B yen versus operating income of negative 2.4B yen shows minimal non-operating impact of approximately 20M yen, indicating earnings are primarily driven by core operations without material financial engineering. Non-operating income represents less than 0.1% of revenue, comprising primarily financial expenses and minimal equity method gains. The small gap between operating and ordinary income suggests transparent earnings composition. Interest expenses appear contained despite the increase in long-term debt to 8.4B yen, though interest coverage ratio of negative 25.47x reflects the challenge of servicing debt while operating at a loss. The absence of cash flow statement data for the quarterly period limits assessment of cash-backed earnings quality. However, the accumulation of operating losses consuming retained earnings by 2.0B yen and the need for external debt financing of 7.5B yen suggest operating activities have not generated sufficient cash to fund growth organically. The stable gross margin of 27.5% indicates consistent product-level economics, but the inability to translate this into positive operating income due to fixed cost burden represents a fundamental earnings quality concern requiring operating leverage improvement.
The company maintains full-year guidance of revenue 49.3B yen, operating loss 1.3B yen, and ordinary loss 1.4B yen. Against this guidance, Q3 cumulative progress shows revenue at 34.0B yen representing 69.0% of full-year target, operating loss at 2.4B yen representing 185% of full-year loss guidance, and ordinary loss at 2.4B yen representing 171% of full-year loss forecast. Revenue progress of 69.0% at the Q3 stage (versus standard 75% benchmark) indicates revenue is tracking 6 percentage points behind typical progression, suggesting potential shortfall risk or fourth-quarter weighting. More notably, cumulative operating loss has already exceeded the full-year loss guidance by 85%, implying the company expects significant fourth-quarter improvement to achieve only 1.3B yen full-year operating loss. This requires Q4 operating profit of approximately 1.1B yen to offset the 2.4B yen cumulative loss, representing a substantial sequential turnaround. The implied Q4 operating margin would need to reach approximately 7% on expected Q4 revenue of 15.3B yen, a dramatic improvement from the negative 7.1% margin through Q3. This guidance assumes either material cost reduction, revenue acceleration, or seasonal profitability patterns not yet evident in year-to-date results.
The company maintains a zero dividend policy for FY2026, with no interim or year-end dividends planned. The dividend forecast confirms 0.00 yen per share for the full year, resulting in a payout ratio of 0% against the forecasted loss of 34.33 yen per share. Given the operating loss position and net loss of 2.2B yen in Q3 cumulative results, dividend distribution would be financially inappropriate and inconsistent with capital preservation principles. The absence of share buyback disclosures indicates no capital return through repurchases. Total shareholder return ratio therefore stands at 0%. While the company maintains cash and deposits of 9.4B yen, deployment of cash toward dividends or buybacks while operating at a loss would undermine financial stability and growth investment capacity, particularly given the 7.5B yen increase in long-term debt that appears to be funding operations and capital expenditures. Shareholder return resumption would require achievement of sustained profitability and positive free cash flow generation.
Operating leverage risk represents the most critical concern, with SG&A expenses of 11.8B yen (34.6% of revenue) structurally exceeding gross profit of 9.3B yen (27.5% margin), creating a 472.0M yen unallocated corporate cost burden. Unless revenue scales sufficiently to absorb fixed costs or cost restructuring reduces the expense base, operating losses will persist. Second, working capital management risk is evidenced by receivables turnover of 61 days and accounts receivable of 5.6B yen representing 14.7% of total assets, indicating potential collection delays that could strain cash flow despite adequate current liquidity. Third, debt servicing risk has emerged with long-term loans increasing 820% to 8.4B yen, raising interest obligations while operating losses continue; the interest coverage ratio of negative 25.47x quantifies this burden, requiring urgent return to operating profitability to sustainably service debt.
[Industry Position] (Reference - Proprietary Analysis)
JSH Corporation's financial metrics show notable divergence from IT and Telecommunications industry medians. Profitability metrics indicate significant underperformance: operating margin of negative 7.1% compares unfavorably to industry median of 8.2% (IQR: 3.6%-18.0%), representing a 15.3 percentage point gap. Net profit margin of negative 5.8% falls well below the industry median of 6.0% (IQR: 2.2%-12.7%), placing the company in the bottom quartile. ROE of negative 11.6% substantially lags the industry median of 8.3% (IQR: 3.6%-13.1%), reflecting loss-making operations versus profitable peers. Revenue growth of 24.2% YoY significantly exceeds the industry median of 10.4% (IQR: -1.2%-19.6%), positioning the company in the top quartile for top-line expansion and demonstrating strong market traction despite profitability challenges. Financial health metrics show mixed positioning: equity ratio of 48.7% sits below the industry median of 59.2% (IQR: 42.5%-72.7%), indicating relatively higher leverage. Current ratio of 194.5% compares favorably to the industry median of 215% but remains within the interquartile range, confirming adequate short-term liquidity. Asset turnover of 0.885 exceeds the industry median of 0.67 (IQR: 0.49-0.93), placing the company in the upper half for asset efficiency. Receivables turnover of approximately 61 days aligns with the industry median of 61.25 days (IQR: 45.96-82.69), suggesting collection performance in line with sector norms despite internal warnings. The company's profile reflects a growth-stage business achieving above-median revenue expansion and asset utilization but operating below industry profitability standards due to elevated fixed cost structure, positioning it as a high-growth, low-margin player requiring operational scaling to achieve industry-standard profitability.
※ Industry: IT and Telecommunications (104 companies), Comparison: FY2025 Q3 period, Source: Proprietary analysis
First, JSH demonstrates strong revenue growth momentum at 24.2% YoY, substantially exceeding the 10.4% industry median and indicating successful market penetration and business model scalability. The Regional Revitalization Business segment generates healthy segment-level profitability with 19.1% margin on 2.28B yen revenue, confirming viable unit economics in the core business. Second, the critical challenge lies in the operating structure where 11.8B yen SG&A expenses exceed 9.3B yen gross profit, with 472.0M yen in unallocated corporate costs representing structural drag. The company's ability to achieve operating leverage by growing revenue faster than fixed costs, or implementing cost rationalization, will determine the path to profitability. The substantial fourth-quarter profit improvement implied by full-year guidance (requiring approximately 1.1B yen Q4 operating profit versus 2.4B yen cumulative loss) represents a key test of execution capability. Third, the financial position shows adequate liquidity with 9.4B yen cash and 194.5% current ratio, but the 820% increase in long-term debt to 8.4B yen raises capital structure concerns. With negative operating cash generation implied by loss accumulation and debt-funded growth, the sustainability of the expansion strategy depends on achieving forecast profitability improvements to generate cash for debt servicing and eventual shareholder returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.